Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niko Thio

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
EMBO Reports|August 5, 2024
Identification of resistance mechanisms to small-molecule inhibition of TEAD-regulated transcriptionAishwarya Kulkarni, Varshini Mohan, Tracy T Tang, et al.
Communications Biology|July 16, 2021
Three-dimensional CRISPR screening reveals epigenetic interaction with anti-angiogenic therapyMichael Y He, Michael M Halford, Ruofei Liu, et al.
Cell Death & Disease|March 1, 2024
Caspase-2 protects against ferroptotic cell deathSwati Dawar, Mariana C Benitez, Yoon Lim, et al.
Journal for Immunotherapy of Cancer|May 13, 2022
Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatmentAngela Pizzolla, Simon Paul Keam, Ismael A Vergara, et al.
Cell Death Discovery|September 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancerCarmelo Cerra, Madeleine R C Tancock, Niko Thio, et al.
NAR Genomics and Bioinformatics|August 26, 2024
A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinomaOlivia Craig, Samuel Lee, Courtney Pilcher, et al.
NPJ Breast Cancer|March 21, 2020
The genetic architecture of breast papillary lesions as a predictor of progression to carcinomaTanjina Kader, Kenneth Elder, Magnus Zethoven, et al.
Annals of Surgical Oncology|October 1, 2022
Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal CancerCarlos S Cabalag, Owen W J Prall, John Ciciulla, et al.
Nature Communications|July 8, 2026
Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinomaVan To, Niko Thio, Rebecca Castle, et al.
The Journal of Pathology|March 8, 2019
Atypical ductal hyperplasia is a multipotent precursor of breast carcinomaTanjina Kader, Prue Hill, Magnus Zethoven, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
EMBO Reports|August 5, 2024
Identification of resistance mechanisms to small-molecule inhibition of TEAD-regulated transcriptionAishwarya Kulkarni, Varshini Mohan, Tracy T Tang, et al.
Communications Biology|July 16, 2021
Three-dimensional CRISPR screening reveals epigenetic interaction with anti-angiogenic therapyMichael Y He, Michael M Halford, Ruofei Liu, et al.
Cell Death & Disease|March 1, 2024
Caspase-2 protects against ferroptotic cell deathSwati Dawar, Mariana C Benitez, Yoon Lim, et al.
Journal for Immunotherapy of Cancer|May 13, 2022
Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatmentAngela Pizzolla, Simon Paul Keam, Ismael A Vergara, et al.
Cell Death Discovery|September 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancerCarmelo Cerra, Madeleine R C Tancock, Niko Thio, et al.
NAR Genomics and Bioinformatics|August 26, 2024
A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinomaOlivia Craig, Samuel Lee, Courtney Pilcher, et al.
NPJ Breast Cancer|March 21, 2020
The genetic architecture of breast papillary lesions as a predictor of progression to carcinomaTanjina Kader, Kenneth Elder, Magnus Zethoven, et al.
Annals of Surgical Oncology|October 1, 2022
Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal CancerCarlos S Cabalag, Owen W J Prall, John Ciciulla, et al.
Nature Communications|July 8, 2026
Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinomaVan To, Niko Thio, Rebecca Castle, et al.
The Journal of Pathology|March 8, 2019
Atypical ductal hyperplasia is a multipotent precursor of breast carcinomaTanjina Kader, Prue Hill, Magnus Zethoven, et al.
Pageof 2